ScholarWorks@Korea University: Lim, Do Sun

Detailed Information

Lim, Do Sun (임도선)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 02-920-5445
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:12||coronary artery disease:5||myocardial infarction:5||drugeluting stent:5||metabolic syndrome:4||acute myocardial infarction:4||drugeluting stents:4||clinical outcome:4||Myocardial infarction:4||Percutaneous coronary intervention:3||Bifurcation:3||hypertension:3||diabetes:3||Atrial fibrillation:3||Endothelial progenitor cell:3||P19 embryonal carcinoma stem cells:2||DrugEluting Stent:2||atrial fibrillation:2||Neointima:2||gradient nanopattern plates:2||Metabolic syndrome:2||Angiogenesis:2||cardiomyogenic differentiation:2||coronary disease:2||Stroke:2||Mesenchymal stem cells:2||Percutaneous Coronary Intervention:2||Promoter:2||Reporter gene:2||drugeluting stent(s):2||Platelet reactivity:2||central blood pressure:2||Everolimus:2||Left main disease:2||amlodipine:2||restenosis:2||RNA interference:2||Drugeluting stents:2||major adverse cardiac event:2||inflammation:2||DsRed:2||clopidogrel:2||coronary artery bypass grafting:2||siRNA:2||Nanog:2||Cardiomyogenic differentiation:2||Clopidogrel:2||genotype:2||Percutaneous coronary interventions:1||Major adverse cardiac event:1||Sca1+cardiac stem cell:1||left ventricular ejection fraction:1||Optical coherence tomography:1||peripheral arterial disease:1||treatment outcome:1||Flk1positive mesodermal precursor cells:1||cytoskeleton reorganization:1||cardiac remodeling:1||Zotarolimus:1||Clinical sample pretreatment:1||Immunosensing performances:1||Cytokines:1||ES CELLS:1||reporter genes:1||Diagnosis:1||cytochrome P450 CYP2C19:1||P2Y12 receptor gene polymorphism:1||guideline adherence:1||recurrence:1||GelMAcollagen hydrogel:1||bleeding risk:1||ischemic risk:1||hypertensive metabolic syndrome:1||Bioengineering:1||anodic aluminum oxide:1||physical stimulation:1||Insulin:1||Transradial Approach:1||Quality control:1||high ischaemic risk:1||Instent restenosis:1||Cardiac sphere:1||Acute coronary syndrome:1||Newonset diabetes:1||Catechin:1||ticagrelor:1||Endovascular procedures:1||Arterial intima:1||Adipose stem cell:1||Induced cardiomyocytelike cells:1||Coronary artery fistula:1||arteries:1||stiffness:1||GENEEXPRESSION MEASUREMENTS:1||HUMAN BLASTOCYSTS:1||Angiogenic cell:1||vascular endothelial growth factor:1||dual promoters:1||racemic:1||Biomarkers:1||elderly:1||Remodeling:1||left:1||Atrial appendage:1||highintensity interval training:1||platelet function:1||cardiac organoids:1||vascularized cardiac organoids:1||East Asian people:1||dual antiplatelet therapy:1||dual drugeluting stent:1||Cilotax (TM) stent:1||Transcatheter aortic valve replacement:1||Hindlimb ischemia:1||Left main:1||Drugeluting stent:1||anticoagulants:1||stroke:1||postprocedural anticoagulation:1||Statin:1||Platelet inhibitors:1||Ticagrelor:1||Extracellular matrix:1||obesity:1||diabetic patients:1||intramyocardial injection:1||MCP1:1||longterm outcome:1||Bronchial artery fistula:1||stents:1||Circulating stem cells:1||ACTIVATING TRANSCRIPTION FACTOR3:1||TUMORSUPPRESSOR:1||PROGENITOR CELLS:1||pioglitazone:1||dimethyl sulphoxide:1||embryoid body:1||nicotinate:1||side population cells:1||Electrical cardioversion:1||catheter ablation:1||cytokines:1||antiplatelet theraphy&nbsp:1||coronary balloon:1||East Asia:1||nanoimprint lithography:1||extracellular matrix:1||Hemoglobin (A1c):1||Heart Failure:1||coronary intervention:1||stent(s):1||Poor metabolizer:1||Nonclinical testing:1||Nanotopography:1||FAK signaling:1||Seoul:1||outcome assessment:1||Cardioprotection:1||left ventricular remodeling:1||Focal adhesion:1||Angiotensin receptor blockers:1||ADSC sheet:1||community health service:1||prevention:1||Sphere:1||Fibroblast growth factor 2:1||Microfluidic system:1||Strain:1||Diabetes:1||Baseline drift correction:1||Pulmonary trunk:1||RETINOIC ACID:1||stent thrombosis:1||hypoxia:1||angiogenesis:1||epicardial fat:1||LEFTYPITX2 signaling:1||Embryoid bodies:1||Embryonic stem cells:1||longterm antiplatelet therapy:1||stable:1||Thymosin beta 4:1||Endothelial Differentiation:1||Vascularization:1||SDF1 alpha:1||Pitavastatin:1||radial arteries:1||infarct size:1||HDLcholesterol:1||Sirolimus:1||cardiovascular diseases:1||cardiomyocyte survival:1||black raspberry:1||Mouse fibroblasts:1||Continuous immunosensor:1||Endothelialcolony forming cell:1||Adult peripheral blood:1||NEURONAL DIFFERENTIATION:1||Coronary flow reserve:1||P19 embryonal carcinoma cells:1||Milk fat globuleEGF factor8:1||Dietary guidelines:1||Catheter ablation:1||pluripotent stem cells:1||3D bioprinting:1||coronary bifurcation lesion:1||endothelial function:1||Coronary stenosis:1||statin:1||human endothelial colonyforming:1||Ventricular cardiac organoid:1||Cardiac mesoderm cells:1||ECMintegrins:1||Focal adhesion signaling:1||Platelet Reactivity:1||Clinical Outcome:1||Cardiac organoids:1||Requirements:1||Cardiomyocyte differentiation:1||angina:1||survival:1||thrombosis:1||Ischemic postconditioning:1||sTsegment elevation myocardial infarction:1||causal mediation analysis:1||coronary artery aneurysm:1||Aspirin:1||Human endothelial colonyforming cells:1||pleiotropic effect:1||nanoimprintiug:1||engraftment:1||Carotid artery:1||immortalization:1||secretome:1||major adverse cardiac events:1||endothelial progenitor cells:1||Vascular endothelial growth factor receptor:1||Small molecule:1||MicroRNA:1||Ischemic hindlimb:1||Adipose:1||Stem cell:1||SELFRENEWAL:1||endothelial differentiation:1||graft survival:1||ventricular function:1||antiplatelet therapy:1||Issue 137:1||LIMK/Cofilin signaling:1||multivessel disease:1||risk factors:1||high bleeding risk:1||femoral arteries:1||left atrial appendage occlusion:1||coronary artery calcification:1||Rhoassociated protein kinase:1||acute coronary syndrome:1||adiposederived stem cell:1||Arterial media:1||Left atrial appendage occlusion:1||in vitro angiogenesis:1||Left ventricle:1||Smooth muscle progenitor cell:1||Neovascularization:1||Aorta:1||calcium channel blocker:1||MICROARRAY PLATFORMS:1||Lateloss:1||zotarolimuseluting stent:1||endothelial cell differentiation:1||mesenchymal stem cells:1||bone marrow:1||echocardiography:1||2stenting technique:1||differentiation:1||ST elevation myocardial infarction:1||predictor:1||direct oral anticoagulants:1||lowdensity lipoprotein cholesterol:1||Diabetes mellitus:1||Stenting:1||Proton pump inhibitor:1||Organoid manufacturing:1||Standard protocol:1||DXR (TM) stent:1||target organ damage:1||Aortic valve stenosis:1||Chronic coronary total occlusion:1||Adiposederived stem cells:1||Drug coated balloon:1||CXCR4:1||Sex difference:1||Stent:1||Gradient nanopattern plates:1||pulse wave velocity:1||prasugrel:1||cardiomyocyte differentiation:1||Restenosis:1||Risk assessment:1||lifestyle:1||cardiac stem cells:1||diabetes mellitus:1||augmentation index:1||Poly2hydroxyethyl methaciylate:1||Lineage conversion:1||Endothelial function:1||Pioglitazone:1||Antiserum aggregation:1||losartan:1||aspirin:1||ischemic postconditioning:1||Pluripotent embryonic stem cell markers:1||Acute myocardial infarction:1||carcinoma cells:1||heart volume:1||Adjunctive pharmacotherapy:1||cardiac:1||porous mesh structure:1||coronary bifurcation stenting:1||Factor Xa inhibitors:1||race:1||Angioplasties:1||secondary prevention:1||Cardiac maturation:1||mature cardiac organoids:1||bypass surgery:1||Bleeding:1||Nanopillar surface:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE